SpaceX Scrubs Starship Test Flight Reschedules for Friday Marks Debut of Upgraded V3 Rocket Arsenals Brand Power How Cultural Reach Sustains Commercial Value Despite OnField Struggles HighYield Savings Account Rates Top 41 APY as of May 23 2026 Consumer Price Index Rises 38 Annually in April Exceeding Expectations and Marking Highest Level Since May 2023 Irans President Orders Reopening of International Internet Access Signal of Policy Shift Indias Labor Market Faces Pressure as Iran Conflict Disrupts Remittances and Trade FCBC Q1 2026 Earnings Slight EPS Miss Amid Flat Revenue Stock Inches Higher BNZI Q1 2026 Earnings Significant EPS Miss Amid Operational Challenges SLB Q1 2026 Earnings EPS Misses Estimates by Narrow Margin Despite Stable Revenue IEP Q1 2026 Earnings Severe EPS Miss as Results Fall Short of Expectations SON Q1 2026 Earnings Mixed Results as EPS Falls Short of Estimates LEXX Q1 2026 Earnings Narrower Loss Surprises as Bioscience Firm Advances Drug Delivery Pipeline Intercontinental Exchange ICE Trades Flat Near Resistance as Consolidation Continues NioCorp Developments NB Surges 76 as Momentum Builds Toward Key Resistance SAJ Notes Hold Steady at 254 Yield Advantage and Key Technical Levels in Focus Bluerock Homes Trust BHM Edges Higher Navigating Support and Resistance at 1062 Iron Horse Acquisitions Corp II Rights IRHOR Holds Steady Near Support as Trading Volume Remains Light South Korea Deputy PM Warns AI May Widen Wealth Gap Amid Samsung Labor Unrest Kazatomproms Q3 Production Surges 17 Signaling Strong Uranium Output Growth US Government Stake Speculation IonQ Micron and Anduril Emerge as Potential Targets After Quantum Investments Nvidia Earnings Call in Focus as Market Awaits Commentary on China Chip Policy and Trump Tariffs Malaysian Food Startup Seeks to Bring LabGrown Unagi to Market Signos Raises 20 Million and Expands Dexcom Partnership to Capitalize on GLP1 Weight Loss Trend with AI Health Tracking Saga Communications SGA Q1 2026 Earnings Negative EPS of 043 Reflects Persistent Industry Headwinds Palvella Therapeutics PVLA Slips 166 as Shares Test Key Support Levels